← FDA DRUG APPROVALS

FDA ANDA · ANDA074877

PENTOXIFYLLINE

Sponsor: HERITAGE

APPLICATION
ANDA074877
TYPE
ANDA
ORIGINAL APPROVAL
1997-07-08
LATEST ACTION
2000-04-05
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Discontinued

Products

PENTOXIFYLLINEDiscontinued
PENTOXIFYLLINE 400MG · TABLET, EXTENDED RELEASE · ORAL

Approval history

2000-04-05Manufacturing (CMC) · Supplement 5AP
1998-07-16Labeling · Supplement 3AP
1998-06-16Manufacturing (CMC) · Supplement 2AP
1998-01-29Manufacturing (CMC) · Supplement 1AP
1998-01-29Manufacturing (CMC) · Supplement 4AP
1997-07-08OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →